LYTACs, or LYsosome TArgeting Chimeras, are cutting-edge bifunctional molecules designed to target and degrade specific proteins outside cells by directing them to the lysosome, a cellular organelle responsible for degradation.

By harnessing the cell’s natural lysosomal degradation pathway, LYTACs can target and eliminate disease-associated proteins present outside of cells, including those involved in inflammation, cancer, and neurodegenerative disorders